Safety and Efficacy of Transcranial Random Noise Stimulation in Psychiatric Disorders: A Systematic Review
Clinical Psychopharmacology and Neuroscience · 28.02.2026 · 24 (1) · 40-57
DOI: 10.9758/cpn.25.1341 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Psychopharmacology and Neuroscience, online erschienen am 04.12.2025. Verfasst von Adarsh Tripathi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, King George's Medical University, Lucknow, Uttar Pradesh, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Transcranial random noise stimulation (tRNS) is a non-invasive brain stimulation technique that modulates cortical excitability through stochastic resonance. While promising, its safety and efficacy in psychiatric disorders remain underexplored.
Objective
To systematically evaluate the efficacy and safety of tRNS in various psychiatric disorders.
Methods
A systematic review was conducted per PRISMA guidelines and registered on PROSPERO (CRD420251040192). Databases searched included CENTRAL-Cochrane Central Register of Controlled Trials, PubMed, Scopus, and Web of Science. Studies were included from their inception to 30th April, 2025. Studies involving tRNS in psychiatric populations, regardless of study design, were included. The risk of bias was assessed using JBI tools.
Results
22 studies were included (642 individuals), spanning ADHD, depression, schizophrenia, dyslexia, and other conditions. Most studies used 20-minute tRNS sessions over 1-4 weeks. ADHD and dyslexia showed consistent improvements in overall executive function and reading & phonological skills, respectively. Schizophrenia studies demonstrated significant reductions in negative symptoms and auditory hallucinations. Effects in depression were mixed, with some studies reporting substantial symptom relief, while others found no significant benefit. Across disorders, tRNS was generally well-tolerated with only mild, transient adverse effects. Conclusion: tRNS appears to be a safe, well-tolerated, and potentially effective intervention for specific psychiatric symptoms, especially in ADHD, dyslexia, and schizophrenia. However, inconsistent protocols and mixed outcomes in mood disorders highlight the need for standardized protocols and further research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, King George's Medical University, Lucknow, Uttar Pradesh, India.
- Department of Psychiatry, All India Institute of Medical Sciences, Mangalagiri, Andhra Pradesh, India.
- Department of Psychiatry, National Institute of Mental Health & Neuro Sciences, Bengaluru, Karnataka, India.
ORCID-Profile: Adarsh Tripathi, Pritanshi Jeswani, Surobhi Chatterjee, Rini Joseph, Sujita Kumar Kar
Zitieren
APA
Tripathi, A., Jeswani, P., Chatterjee, S., Joseph, R., & Kar, S. K. (2026). Safety and Efficacy of Transcranial Random Noise Stimulation in Psychiatric Disorders: A Systematic Review. Clinical Psychopharmacology and Neuroscience, 24(1), 40-57. https://doi.org/10.9758/cpn.25.1341
Vancouver
Tripathi A, Jeswani P, Chatterjee S, Joseph R, Kar SK. Safety and Efficacy of Transcranial Random Noise Stimulation in Psychiatric Disorders: A Systematic Review. Clinical Psychopharmacology and Neuroscience. 2026;24(1):40-57. doi:10.9758/cpn.25.1341
BibTeX
@article{Tripathi2026,
author = {Tripathi, Adarsh and Jeswani, Pritanshi and Chatterjee, Surobhi and Joseph, Rini and Kar, Sujita Kumar},
title = {Safety and Efficacy of Transcranial Random Noise Stimulation in Psychiatric Disorders: A Systematic Review},
journal = {Clinical Psychopharmacology and Neuroscience},
year = {2026},
volume = {24},
number = {1},
pages = {40--57},
doi = {10.9758/cpn.25.1341}
}
EUVIMED